Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy

NCT02420379 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

DRUG: eteplirsen

Sponsor

Sarepta Therapeutics, Inc.